港股收评：恒指跌0.34%失守24000点，药品股大幅走低

Market Overview - The Hong Kong stock market indices collectively declined, with the Hang Seng Index falling by 0.34% to close at 23,980.30, while the Hang Seng Tech Index and the China Enterprises Index dropped by 0.15% and 0.40% respectively [1][2]. Sector Performance - Large technology stocks showed mixed results, with Alibaba rising by 1.68% and Tencent and JD.com experiencing gains of less than 0.8%. However, innovative drug concept stocks saw significant declines, with Green Leaf Pharmaceuticals dropping by 11% and Xiansheng Pharmaceuticals by 10.5% [2][4]. - Defensive sectors such as gold, oil, and military stocks experienced a collective pullback amid easing geopolitical tensions [2]. - The brain-computer interface concept stocks surged, with Nanjing Panda Electronics skyrocketing by 38%, followed by Brainhole Technology and Micron Brain Science with increases of 22.65% and 18.47% respectively [11]. Notable Stock Movements - The pharmaceutical sector faced substantial losses, with companies like Decipher Biosciences and Jiuyuan Gene falling over 11% [6]. - New consumption concepts also declined, with brands like Blukoo and Pop Mart dropping more than 6% [7]. - Real estate stocks collectively retreated, with companies such as Oceanwide Holdings and Jin Hui Holdings experiencing declines of over 4% [8]. - The entertainment sector showed weakness, with New Stone Culture and Bigo Group dropping over 5% [9]. Investment Trends - The gambling sector saw gains, with Sands China increasing by over 5% and MGM China by nearly 5% [14]. - Southbound funds recorded a net inflow of HKD 6.302 billion, indicating strong investor interest [14]. - Analysts suggest that the current valuation of Hong Kong stocks is at a historical average level, with a focus on high-dividend sectors such as energy, finance, and precious metals, as well as innovative drug sectors benefiting from favorable policy news [16].